The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 18.21

Myeloma (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2013
By Race/Ethnicity, Sex and Years Since Diagnosis
Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <21e 0 to <38e >=38g
All Races b Both Sexes 60,408 21,641 8,022 3,226 1,463 481 94,421 95,457 231 95,688
Males 32,121 11,898 4,491 1,669 841 270 50,817 51,385 80 51,465
Females 28,287 9,743 3,531 1,557 622 211 43,604 44,072 151 44,223
White b Both Sexes 44,457 16,678 6,179 2,568 1,076 397 70,751 71,492 0 71,492
Males 24,387 9,669 3,654 1,336 624 216 39,527 39,955 0i 39,955
Females 20,070 7,009 2,525 1,232 452 181 31,224 31,537 0i 31,537
Black b Both Sexes 12,858 4,251 1,497 531 308 63 19,335 19,581 + +
Males 6,057 1,911 648 253 185 49 8,993 9,127 + +
Females 6,801 2,340 849 278 123 14 10,342 10,454 + +
Asian/
Pacific
Islander c
Both Sexes 1,615 445 222 + + + 2,384 + + +
Males 887 221 109 + + + 1,265 + + +
Females 728 224 113 + + + 1,119 + + +
Hispanic d Both Sexes 4,600 1,510 631 + + + 6,994 + + +
Males 2,613 842 332 + + + 3,944 + + +
Females 1,987 668 299 + + + 3,050 + + +
Estimated prevalence percent a on January 1, 2013, of the SEERc population diagnosed in the previous 21 years
By Age at Prevalence, Race/Ethnicity and Sex
Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0264% - - 0.0004% 0.0022% 0.0122% 0.0369% 0.0860% 0.1393% 0.1162% 0.0248%
Males 0.0290% - - 0.0006% 0.0027% 0.0150% 0.0417% 0.1013% 0.1645% 0.1476% 0.0295%
Females 0.0239% - - - 0.0017% 0.0094% 0.0323% 0.0721% 0.1187% 0.0974% 0.0209%
White c Both Sexes 0.0259% - - 0.0004% 0.0021% 0.0109% 0.0335% 0.0801% 0.1316% 0.1104% 0.0231%
Males 0.0293% - - 0.0006% 0.0027% 0.0135% 0.0392% 0.0972% 0.1587% 0.1476% 0.0283%
Females 0.0224% - - - 0.0016% 0.0082% 0.0278% 0.0641% 0.1089% 0.0878% 0.0187%
Black c Both Sexes 0.0429% - - - 0.0036% 0.0282% 0.0782% 0.1774% 0.2730% 0.2301% 0.0506%
Males 0.0417% - - - 0.0043% 0.0336% 0.0757% 0.1948% 0.3122% 0.2370% 0.0549%
Females 0.0439% - - - 0.0030% 0.0234% 0.0804% 0.1638% 0.2457% 0.2267% 0.0474%
Asian/
Pacific
Islander c
Both Sexes 0.0150% - - - 0.0014% 0.0056% 0.0204% 0.0488% 0.0876% 0.0753% 0.0146%
Males 0.0164% - - - 0.0018% 0.0075% 0.0260% 0.0559% 0.1001% 0.0903% 0.0174%
Females 0.0137% - - - 0.0010% 0.0039% 0.0156% 0.0431% 0.0778% 0.0661% 0.0125%
Hispanic d Both Sexes 0.0134% - - 0.0004% 0.0028% 0.0101% 0.0329% 0.0692% 0.1316% 0.0974% 0.0218%
Males 0.0149% - - 0.0007% 0.0036% 0.0132% 0.0397% 0.0854% 0.1498% 0.1256% 0.0265%
Females 0.0119% - - - 0.0019% 0.0069% 0.0263% 0.0552% 0.1181% 0.0804% 0.0180%

Footnotes:

a US 2013 cancer prevalence counts are based on 2013 cancer prevalence proportions from the SEER registries and 1/1/2013 US population estimates based on the average of 2012 and 2013 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 13 Areas excluding the Alaska Native Registry

d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.

e Maximum limited-duration prevalence: 38 years for 1975-2013 SEER 9 data; 21 years for 1992-2013 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 38 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <38 and >=38.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.